Tumor-infiltrating lymphocytes (TILs), frontline soldiers of the adaptive immune system, are
recruited into the tumor site to fight against tumors. However, their small number and …

Breast cancer is a problem for women's health globally. Early detection techniques come in
a variety of forms ranging from local to systemic and from non-invasive to invasive. The …

The HER2-positive patients occupy~ 30% of the total breast cancer patients globally where
no prevalent drugs are available to mitigate the frequent metastasis clinically except …

A robust understanding of the tumor immune environment has important implications for
cancer diagnosis, prognosis, research, and immunotherapy. Traditionally …

Breast cancer (BC) is a malignant neoplasm that begins in the breast tissue. After skin
cancer, BC is the second most common type of cancer in women. At the end of 2040, the …

Breast cancer (BC), one of the most widespread and devastating diseases affecting women
worldwide, presents a significant public health challenge. This review explores the emerging …

Gastric cancer (GC) is a severe malignancy, accounting for the third most common cancer
death worldwide. Despite the development of chemo-radiation therapy, there has not been …

Breast cancer (BC) is the most common malignancy among females. Chemotherapy drugs
remain the cornerstone of treatment of BC and undergo significant shifts over the past 100 …

The role of inflammation in cancer is a topic that has been investigated for many years. As
established, inflammation emerges as a defining characteristic of cancer, presenting itself as …

Abstract Background Studies on PD-L1 expression in breast cancer have gained importance
in recent years, especially in triple-negative breast cancer (TNBC). Our aim was to analyze …